Drugs and Treatment Archives

Text Size:
Email This Post Email This Post Print This Post Print This Post

What works, and what doesn’t, in the battle against Alzheimer’s: A look at new medications and novel therapies undergoing testing and development.

Second Brain Imaging Drug Approved for Alzheimer’s Diagnosis

The Food and Drug Administration approved a new brain imaging drug for use in the diagnosis of Alzheimer’s disease, the second such drug to be approved for use in the United States. The approval expands options for those undergoing brain … Continue reading

Solanezumab to Be Tested in Large Trial for Early Alzheimer’s

The drug maker Eli Lilly is proceeding with trials of an experimental drug called solanezumab to treat early Alzheimer’s, despite earlier research in which the drug had failed to meet study goals. In earlier research the drug had shown hints … Continue reading

Can Vitamin E Slow Alzheimer’s Decline?

An intriguing new study suggests that vitamin E supplements may be helpful to patients with mild to moderate Alzheimer’s disease. Those who took the vitamin were better able to carry out activities like getting dressed, bathing and having a meal … Continue reading

Alzheimer’s Drugs May Have Heart Benefits

Medications commonly used to treat Alzheimer’s disease may have another benefit: they may reduce the risk of having a heart attack. Drugs like donepezil (brand name Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are commonly given to those in the earlier … Continue reading

Experimental Drug Solanezumab Shows Hints of Promise

An experimental drug showed promise of slowing cognitive decline in people in the early stages of Alzheimer’s, though the benefits were modest and the drug did not meet its main testing goals in a study of patients with mild to … Continue reading

Blood Pressure Drugs May Help Slow Alzheimer’s

Doctors found that patients taking a certain class of drugs used to treat high blood pressure had less of the brain plaque characteristic of Alzheimer’s disease after they died. The findings suggest that the drugs, known as angiotensin receptor blockers, … Continue reading

Drug Makers Halt Testing of Bapineuzumab for Alzheimer’s

Makers of the experimental drug bapineuzumab, which earlier studies suggested might be beneficial in fighting Alzheimer’s disease, announced that they had halted testing of the drug. The announcement came after late-stage testing found that it did not show benefits in … Continue reading

Low-Dose Aspirin May Benefit the Brain

Do you take a daily baby aspirin to prevent heart disease? It may be good for your brain as well, a new study suggests. An analysis of elderly Swedish women at high risk for cardiovascular disease found that regularly taking … Continue reading

Three Drugs to Be Tested to Prevent Alzheimer’s

Scientists have chosen three drugs to be tested as a way to prevent the onset of Alzheimer’s disease in people who are genetically predisposed to get the disease at an early age. If one or more of the medications prove to … Continue reading

Gammagard Shows Early Promise Against Alzheimer’s

An immune system drug called Gammagard showed initial promise against stemming the decline of Alzheimer’s disease in an early-stage trial in a very small number of patients. Much more testing will be needed, but scientists are cautiously optimistic that the … Continue reading